Mar 01, 2019 - Spectrum Pharma (SPPI) misses bottom-line estimates in the fourth quarter but beats on revenues.
Feb 26, 2019 - Names on the move ahead of the open.
Feb 25, 2019 - A Delaware jury has confirmed the validity of two Amgen (NASDAQ:AMGN) patents covering high cholesterol med Repatha (evolocumab), specifically, the antibodies that bind to a specific region on PCSK9 a
Feb 25, 2019 - In the face of a slowing economy, companies with low operating leverage should outperform, according to Goldman Sachs.
Feb 25, 2019 - Roche (RHHBY) to acquire Philadelphia-based gene therapy company, Spark Therapeutics, Inc. (ONCE) at a price of $114.50 per share in an all-cash transaction.
Feb 22, 2019 - Amgen (AMGN) and partners started enrollment for the second phase III study of omecamtiv mecarbil, which is being developed for the potential treatment of heart failure with reduced ejection fraction.
Feb 22, 2019 - Putnam Fl Investment Management Co Buys Amgen Inc, CVS Health Corp, Cisco Systems Inc, Sells Aetna Inc, Invesco QQQ Trust Series 1, Facebook Inc, Stocks: AMGN,CVS,CSCO,IEFA,DRI,BAC,MAS,PBCT,MDT,XLE,AJG,BH, release date:Feb 22, 2019
Feb 21, 2019 - The Zacks Analyst Blog Highlights: Walmart, Amgen, Honda, TransCanada and TransUnion
Feb 21, 2019 - Merck's (MRK) sBLA looking for approval of Keytruda monotherapy for the third-line treatment of small cell lung cancer, a difficult-to-treat cancer, gets FDA's priority review.
Feb 20, 2019 - Top Analyst Reports for Walmart, Amgen and Honda